Prestigious Prize Recognizes Pioneering Immune System Discoveries

The prestigious award in medical science was awarded for revolutionary discoveries that illuminate how the body's defense network attacks dangerous infections while protecting the body's own cells.

Three renowned scientists—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.

Their work uncovered specialized "security guards" within the defense system that remove rogue immune cells capable of harming the body.

These findings are now paving the way for innovative treatments for immune disorders and cancer.

These winners will share a monetary award valued at 11 million SEK.

Decisive Discoveries

"The work has been decisive for understanding how the immune system functions and the reason we don't all develop serious autoimmune diseases," commented the head of the Nobel Committee.

This team's research explain a fundamental mystery: In what way does the defense system defend us from countless infections while leaving our healthy cells unharmed?

Our body's protection system employs white blood cells that search for indicators of infection, including viruses and bacteria it has never encountered.

These cells utilize sensors—known as recognition units—that are generated by chance in a vast number of variations.

That gives the defense network the capacity to combat a broad range of threats, but the unpredictability of the process inevitably creates immune cells that can target the body.

Security Guards of the Body

Scientists earlier knew that a portion of these problematic defense cells were destroyed in the immune organ—the site where white blood cells develop.

This year's Nobel Prize recognizes the discovery of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to disarm other immune cells that attack the body's own tissues.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel stated, "These discoveries have laid the foundation for a new field of investigation and spurred the development of innovative treatments, for example for tumors and autoimmune diseases."

Regarding cancer, T-regs prevent the system from attacking the growth, so research are aimed at reducing their numbers.

For self-attack disorders, experiments are exploring boosting regulatory T-cells so the body is no longer under attack. A similar method could also be effective in minimizing the risks of organ transplant rejection.

Innovative Experiments

Professor Shimon Sakaguchi, from Osaka University, performed tests on rodents that had their thymus extracted, causing self-attack conditions.

The researcher showed that injecting defense cells from healthy animals could prevent the disease—suggesting there was a system for blocking immune cells from harming the body.

Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an genetic immune disorder in mice and people that resulted in the identification of a gene critical for how regulatory T-cells function.

"The pioneering research has revealed how the immune system is kept in check by T-reg cells, preventing it from mistakenly targeting the body's own tissues," said a leading physiology expert.

"The research is a remarkable illustration of how basic physiological research can have far-reaching implications for human health."